Alvotech, Bioventure obtain approval for Humira biosimilar in Egypt
Alvotech and Bioventure received the Egyptian Drug Authority's approval to produce and supply AVT02 (adalimumab), a biosimilar for Humira.
Source: pharmaceutical-technology.com
Ashraf Radwan News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ashraf Radwan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ashraf Radwan Today - Breaking & Trending Today
Alvotech and Bioventure Announce Approval of AVT02
Approval of Adalimumab-EVA™ represents the second biosimilar approval under the strategic partnership between Alvotech and Bioventure Alvotech (NASDAQ:...
Source: globenewswire.com
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) in Egypt - Alvotech (NASDAQ:ALVO)
REYKJAVIK, Iceland and DUBAI, United Arab Emirates, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO) and Bioventure, a wholly owned subsidiary of GlobalOne Healthcare Holding LLC, today announced that the
Source: benzinga.com
Saudi-based AJA Pharma and the UAE's Bioventure agree deal to license and supply new pharmaceuticals
RIYADH: Saudi-based AJA Pharma has signed a Memorandum of Understanding with UAE’s Bioventure FZ-LLC to license and supply new pharmaceutical products. According to a bourse filing, the new additional selected pharmaceutical products in the Middle East region are set to be used in the Saudi Export stand at the upcoming Arab Health Expedition 2023. Under the terms of the new
Source: arabnews.com
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com